Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.120
+0.010 (0.89%)
At close: Dec 5, 2025, 4:00 PM EST
1.140
+0.020 (1.79%)
After-hours: Dec 5, 2025, 7:59 PM EST
Citius Oncology Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| Selling, General & Admin | 18.84 | 15.65 | 7.88 | 2.86 |
| Research & Development | 6.64 | 4.93 | 4.24 | 6.86 |
| Operating Expenses | 25.48 | 20.57 | 12.12 | 9.71 |
| Operating Income | -25.48 | -20.57 | -12.12 | -9.71 |
| Pretax Income | -25.64 | -20.57 | -12.12 | -9.71 |
| Income Tax Expense | 0.94 | 0.58 | 0.58 | 1.15 |
| Net Income | -26.58 | -21.15 | -12.7 | -10.87 |
| Net Income to Common | -26.58 | -21.15 | -12.7 | -10.87 |
| Shares Outstanding (Basic) | 71 | 68 | 68 | 34 |
| Shares Outstanding (Diluted) | 71 | 68 | 68 | 34 |
| Shares Change (YoY) | 5.32% | 0.82% | 100.00% | - |
| EPS (Basic) | -0.37 | -0.31 | -0.19 | -0.32 |
| EPS (Diluted) | -0.37 | -0.31 | -0.19 | -0.32 |
| EBIT | -25.48 | -20.57 | -12.12 | -9.71 |
Source: S&P Capital IQ. Standard template.
Financial Sources.